Vedanta Resources is trying to raise around $1 billion in debt financing to fund development of its Konkola Copper Mines (KCM) in Zambia, Chris Griffith, head of the company’s base metals unit, said.
Berhampur: Authorities of Berhampur University (BU) have sought over Rs 8.70 crore from the state govt for constructing a boundary wall adjoining the boys' hostels after the institute handed over ...
Jharsuguda, Odisha; February 3rd, 2025: Vedanta Aluminium, India’s largest producer of aluminium, conducted a month-long road safetyinitiative in Jharsuguda and Kalahandi in Odisha, which positively ...
Jharsuguda: The Tamang community in Jharsuguda celebrated their traditional New Year festival, Sonam Lochar, with grand festivities near OMP School here on Thursday, showcasing their rich cultural ...
BHUBANESWAR: Global aluminium major Vedanta Limited on Tuesday signed a memorandum of understanding (MoU) worth Rs 1 lakh crore with the Government of Odisha, on the opening day of Utkarsh Odisha ...
Vedanta’s current investments have led to the creation of the world’s largest single-location aluminium smelter at Jharsuguda, in addition to a world-class refinery at Lanjigarh. Odisha has ...
Vedanta will establish a Rs 1 lakh crore aluminium refinery and smelter in Raygada, Odisha. The first phase will start in the next three years. The company has already invested over Rs 1 lakh crore in ...
Vedanta group has already made significant investments in Odisha, amounting to more than Rs 1 trillion, Agarwal said. The company is now operating a 1.8 MTPA smelter in Jharsuguda and a 3.5 MTPA ...
Vedanta operates a 3.5 million tonnes per annum capacity alumina refinery in Lanjigarh, Kalahandi district since 2007 and an associated 75 MW captive power plant. Besides, the Group operates the world ...
Vedanta Ltd, the dividend king stock, is all set to declare its Q3 financial results on January 31. The announcement of the date was made on Monday when Vedanta stock dipped by over 4% on BSE.
CAMBRIDGE, Mass., January 23, 2025 -- Vedanta Biosciences, a late clinical-stage company developing defined bacterial consortia as oral therapies for gastrointestinal diseases, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results